SCHEMBL21754796

SCHEMBL21754796

CC1O[C@H](COC(=O)c2ccc(Cl)cc2)[C@@H](OC(=O)c2ccc(Cl)cc2)[C@@H]1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UPP1 Q16831 1/20 0.48
PTPN1 P18031 4/20 0.46
CHRNB2 P17787 1/20 0.42
CHRNA5 P30532 1/20 0.42
CHRNA7 P36544 1/20 0.42
CHRNA4 P43681 1/20 0.42
GAPDH P04406 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 1/20 0.41
POLB P06746 2/20 0.39
F11 P03951 2/20 0.39
USP2 O75604 2/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.38
PTPN2 P17706 1/20 0.38
PTPN11 Q06124 1/20 0.38
ELANE P08246 1/20 0.38
ALDH1A1 P00352 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21754792 0.89 HPGD (0.46) UPP1PTPN1MEN1KMT2ACYP1A2
SCHEMBL26291341 0.88 POLB (0.49) PTPN1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL14931047 0.88 POLB (0.49) PTPN1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL16926957 0.88 POLB (0.49) PTPN1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL14208949 0.88 POLB (0.49) PTPN1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL8389853 0.88 POLB (0.49) PTPN1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL25509971 0.88 POLB (0.49) PTPN1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL25510429 0.88 POLB (0.49) PTPN1CHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL21754762 0.87 PTPN1 (0.45) PTPN1GAPDHMEN1KMT2ACYP2C19
SCHEMBL16756914 0.86 UPP1 (0.49) UPP1PTPN1CHRNB2CHRNA5CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10570112-B2 Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same FUJIFILM CORPORATION (JP) 2020-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570112-B2 Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same TYMS, TYMP, RRM2B UPP1 201/4885PTPN1 4173/4885CHRNB2 2595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.